CHINA GEWANG BIOTECHNOLOGY, INC. Increase (Decrease) in Accounts Receivable
CHINA GEWANG BIOTECHNOLOGY, INC. reported Increase (Decrease) in Accounts Receivable of $3.13 million for the 6-month period ending 2017-05-31, per its 10-Q filed 2017-07-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2017-07-17
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accounts receivable for the quarter ending 2017-05-31 was -$37.27K, a 101.13% decline year-over-year.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accounts receivable for the quarter ending 2017-02-28 was $3.17M, a 11757.90% increase year-over-year.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accounts receivable for the quarter ending 2016-05-31 was $3.30M.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accounts receivable for the quarter ending 2016-02-29 was $26.73K.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accounts receivable for fiscal 2016 was $10.94M, a 3983.03% increase from fiscal 2015.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accounts receivable for fiscal 2015 was $267.87K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-05-31 | -$37.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-17 | $3.13M 10-Q · filed 2017-07-17 | |||||
| 2017-02-28 | $3.17M 10-Q · filed 2017-04-12 | ||||||
| 2016-11-30 | $10.94M 10-K · filed 2017-02-10 | ||||||
| 2016-05-31 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-17 | $3.33M 10-Q · filed 2017-07-17 | -$3.33M 10-Q · filed 2016-07-15 | $3.89M derived: sum of 3 quarters · filed 2017-07-17 | $3.89M derived: sum of 4 quarters · filed 2017-07-17 | ||
| 2016-02-29 | $26.73K 10-Q · filed 2017-04-12 | -$26.73K 10-Q · filed 2016-04-15 | $587.19K derived: sum of 2 quarters · filed 2017-04-12 | $587.19K derived: sum of 3 quarters · filed 2017-04-12 | $569.60K derived: sum of 4 quarters · filed 2017-04-12 | ||
| 2015-11-30 | $560.46K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-10 | $560.46K derived: sum of 2 quarters · filed 2017-02-10 | $542.87K derived: sum of 3 quarters · filed 2017-02-10 | $267.87K 10-K · filed 2017-02-10 | -$267.87K 10-K · filed 2016-02-29 | ||
| 2015-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-20 | -$17.59K derived: sum of 2 quarters · filed 2016-10-14 | -$292.59K 10-Q · filed 2015-10-20 | ||||
| 2015-05-31 | -$17.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-10-14 | -$292.59K 10-Q · filed 2016-10-14 | -$222.91K 10-Q · filed 2015-07-22 | ||||
| 2015-02-28 | -$275.00K 10-Q · filed 2016-04-15 |